| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |